Genetic polymorphisms in dopamine-related genes and smoking cessation in women: A prospective cohort study

Behavioral and Brain Functions

Volumn 3, Issue , 2007, Pages

  Ton, Thanh G N ^a   Rossing, Mary Anne ^a,b   Bowen, Deborah J ^b   Srinouanprachan, Sengkeo ^a   Wicklund, Kristine ^b   Farin, Federico M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; FENFLURAMINE; GLYCINE; PLACEBO; SERINE; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DOPAMINE METABOLISM; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; HUMAN; HYPOTHESIS; NEUROTRANSMISSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 34547220462     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-3-22     Document Type: Article

References (44)

1. Arinami T Gao M Hamaguchi H Toru M A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia Hum Mol Genet 1997 6 577-582 10.1093/hmg/6.4.577 9097961
2. Jonsson EG Nothen MM Grunhage F Farde L Nakashima Y Propping P Sedvall GC Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers Mol Psychiatry 1999 4 290-296 10.1038/sj.mp.4000532 10395223
3. Thompson J Thomas N Singleton A Piggott M Lloyd S Perry EK Morris CM Perry RH Ferrier IN Court JA D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele Pharmacogenetics 1997 7 479-484 10.1097/ 00008571-199712000-00006 9429233
4. Lachman HM Papolos DF Saito T Yu YM Szumlanski CL Weinshilboum RM Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 1996 6 243-250 10.1097/ 00008571-199606000-00007 8807664
5. Bowen DJ McTiernan A Powers D Feng Z Recruiting women into a smoking cessation program: Who might quit? Women 2000 31 41-58 10.1300/ J013v31n04_03
6. Cummings SR Richard RJ Optimum cutoff points for biochemical validation of smoking status Am J Public Health 1988 78 574-575 1349344 3354745
7. Davidoff R McTiernan A Constantine G Davis KD Balady GJ Mendes LA Rudolph RE Bowen DJ Echocardiographic examination of women previously treated with fenfluramine: Long-term follow-up of a randomized, double-blind, placebo-controlled trial. Arch 2001 161.
8. Gritz ER Baer-Weiss V Benowitz NL Van Vunakis H Jarvik ME Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users Clin Pharmacol Ther 1981 30 201-209 7195786
9. Jarvis MJ Russell MA Benowitz NL Feyerabend C Elimination of cotinine from body fluids: Implications for noninvasive measurement of tobacco smoke exposure Am J Public Health 1988 78 696-698 1350287 3369603
10. Colilla S Lerman C Shields PG Jepson C Rukstalis M Berlin J DeMichele A Bunin G Strom BL Rebbeck TR Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women Pharmacogenet Genomics 2005 15 393-398 1262648 15900212
11. David SP Johnstone E Griffiths SE Murphy M Yudkin P Mant D Walton R No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation Pharmacogenetics 2002 12 265-268 10.1097/ 00008571-200204000-00011 11927842
12. McKinney EF Walton RT Yudkin P Fuller A Haldar NA Mant D Murphy M Welsh KI Marshall SE Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers Pharmacogenetics 2000 10 483-491 10.1097/00008571-200008000-00001 10975602
13. Redden DT Shields PG Epstein L Wileyto EP Zakharkin SO Allison DB Lerman C Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: An evaluation of nonreplicated results Cancer Epidemiol Biomarkers Prev 2005 14 1384-1389 10.1158/1055-9965.EPI-04-0649 15941945
14. Comings DE Ferry L Bradshaw-Robinson S Burchette R Chiu C Muhleman D The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking Pharmacogenetics 1996 6 73-79 10.1097/00008571-199602000-00006 8845863
15. Spitz MR Shi H Yang F Hudmon KS Jiang H Chamberlain RM Amos CI Wan Y Cinciripini P Hong WK Wu X Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients J Natl Cancer Inst 1998 90 358-363 10.1093/jnci/90.5.358 9498485
16. Noble EP St Jeor ST Ritchie T Syndulko K St Jeor SC Fitch RJ Brunner RL Sparkes RS D2 dopamine receptor gene and cigarette smoking: A reward gene? Med Hypotheses 1994 42 257-260 10.1016/0306-9877(94)90127-9 8072432
17. Freire MT Marques FZ Hutz MH Bau CH Polymorphisms in the DBH and DRD2 gene regions and smoking behavior Eur Arch Psychiatry Clin Neurosci 2006 256 93-97 10.1007/s00406-005-0610-x 16032443
18. Cinciripini P Wetter D Tomlinson G Tsoh J De Moor C Cinciripini L Minna J The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood Nicotine Tob Res 2004 6 229-239 10.1080/14622200410001676396 15203796
19. Swan GE Valdes AM Ring HZ Khroyan TV Jack LM Ton CC Curry SJ McAfee T Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR Pharmacogenomics J 2005 5 21-29 10.1038/ sj.tpj.6500281 15492764
20. Berlin I Covey LS Jiang H Hamer D Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation Nicotine Tob Res 2005 7 725-728 10.1080/14622200500259176 16191743
21. Munafo M Clark T Johnstone E Murphy M Walton R The genetic basis for smoking behavior: A systematic review and meta-analysis Nicotine Tob Res 2004 6 583-597 10.1080/14622200410001734030 15370155
22. Wu X Hudmon KS Detry MA Chamberlain RM Spitz MR D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: A lung cancer case-control study Cancer Epidemiol Biomarkers Prev 2000 9 1021-1026 11045783
23. Yoshida K Hamajima N Kozaki K Saito H Maeno K Sugiura T Ookuma K Takahashi T Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese Cancer Epidemiol Biomarkers Prev 2001 10 403-405 11319183
24. Hamajima N Ito H Matsuo K Saito T Tajima K Ando M Yoshida K Takahashi T Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: A confirmatory study J Epidemiol 2002 12 297-304 12395869
25. Qi J Tan W Xing D Miao X Lin D Study on the association between smoking behavior and dopamine receptor D2 gene polymorphisms among lung cancer cases Zhonghua Liu Xing Bing Xue Za Zhi 2002 23 370-373 12482370
26. Lee HS Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking Am J Med Genet B Neuropsychiatr Genet 2003 118 55-59 10.1002/ajmg.b.10036 12627467
27. Sabol SZ Nelson ML Fisher C Gunzerath L Brody CL Hu S Sirota LA Marcus SE Greenberg BD Lucas FR Benjamin J Murphy DL Hamer DH A genetic association for cigarette smoking behavior Health Psychol 1999 18 7-13 10.1037/0278-6133.18.1.7 9925040
28. Lerman C Caporaso NE Audrain J Main D Bowman ED Lockshin B Boyd NR Shields PG Evidence suggesting the role of specific genetic factors in cigarette smoking Health Psychol 1999 18 14-20 10.1037/0278-6133.18.1.14 9925041
29. Jorm AF Henderson AS Jacomb PA Christensen H Korten AE Rodgers B Tan X Easteal S Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey Am J Med Genet 2000 96 331-334 10.1002/ 1096-8628(20000612)96:3<331::AID-AJMG19>3.0.CO;2-0 10898910
30. Vandenbergh DJ Bennett CJ Grant MD Strasser AA O'Connor R Stauffer RL Vogler GP Kozlowski LT Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: Failure to replicate and finding that never-smokers may be different Nicotine Tob Res 2002 4 333-340 10.1080/14622200210142689 12215242
31. Lerman C Shields PG Main D Audrain J Roth J Boyd NR Caporaso NE Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking Pharmacogenetics 1997 7 521-524 10.1097/00008571-199712000-00012 9429239
32. Anney RJ Olsson CA Lotfi-Miri M Patton GC Williamson R Nicotine dependence in a prospective population-based study of adolescents: The protective role of a functional tyrosine hydroxylase polymorphism Pharmacogenetics 2004 14 73-81 10.1097/00008571-200402000-00001 15077008
33. Olsson C Anney R Forrest S Patton G Coffey C Cameron T Hassett A Williamson R Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health Behav Genet 2004 34 85-91 10.1023/ B:BEGE.0000009478.70863.25 14739699
34. Cohen S Lichtenstein E Prochaska JO Rossi JS Gritz ER Carr CR Orleans CT Schoenbach VJ Biener L Abrams D Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves Am Psychol 1989 44 1355-1365 10.1037/ 0003-066X.44.11.1355 2589730
35. Ward KD Klesges RC Zbikowski SM Bliss RE Garvey AJ Gender differences in the outcome of an unaided smoking cessation attempt. Addict 1997 22 521-533 10.1016/S0306-4603(96)00063-9
36. Bjornson W Rand C Connett JE Lindgren P Nides M Pope F Buist AS Hoppe-Ryan C O'Hara P Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995 85 223-230 1615316 7856782
37. Gritz ER Nielsen IR Brooks LA Smoking cessation and gender: The influence of physiological, psychological, and behavioral factors. J Am Med Women's Assoc 1996 51 35-42
38. Lerman C Shields PG Wileyto EP Audrain J Hawk LH Jr. Pinto A Kucharski S Krishnan S Niaura R Epstein LH Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial Health Psychol 2003 22 541-548 10.1037/0278-6133.22.5.541 14570538
39. Berrettini WH Wileyto EP Epstein L Restine S Hawk L Shields P Niaura R Lerman C Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence Biol Psychiatry 2007 61 111-118 10.1016/j.biopsych.2006.04.030 16876132
40. Lundstrom K Turpin MP Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system Biochem Biophys Res Commun 1996 225 1068-1072 10.1006/bbrc.1996.1296 8780735
41. Asghari V Sanyal S Buchwaldt S Paterson A Jovanovic V Van Tol HH Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants J Neurochem 1995 65 1157-1165 7643093
42. Fuke S Suo S Takahashi N Koike H Sasagawa N Ishiura S The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression Pharmacogenomics J 2001 1 152-156 11911442
43. Heinz A Goldman D Jones DW Palmour R Hommer D Gorey JG Lee KS Linnoila M Weinberger DR Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 2000 22 133-139 10.1016/S0893-133X(99)00099-8 10649826
44. Jonsson E Sedvall G Brene S Gustavsson JP Geijer T Terenius L Crocq MA Lannfelt L Tylec A Sokoloff P Schwartz JC Wiesel FA Dopamine-related genes and their relationships to monoamine metabolites in CSF Biol Psychiatry 1996 40 1032-1043 10.1016/0006-3223(95)00581-1 8915563